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How often do gastroenterologists advise patients
to ‘‘avoid spicy food’’ without really knowing
why? The answer may lie in the family of transient
receptor potential (TRP) channels, which includes
receptors for compounds found in common herbs
and spices. This aim of this review is not really to
answer this question, but it will shed light on why
spices may cause symptoms. Instead, its aim is to
explore the TRP family for potential targets that
may in fact reduce gut symptoms. Chronic pain
and discomfort of unknown origin in functional
gastrointestinal disorders represent a large unmet
need for treatment and consequent economic
impact. There are also features of other gut disease
which generate symptoms with obscure origins. In
order to understand how symptoms are generated
in the gut and transmitted to the central nervous
system, we need to know at least three principles
of extrinsic sensory nerve function—first, what
types are there and what do they signal?; secondly,
what is the molecular basis of sensory transduc-
tion?; and thirdly, how does all of this change in
disease? These questions are a key focus of this
article, with a particular emphasis on the role of
TRP channels in each case. Although there are no
drugs yet available for clinical use that target TRP
channels, some of the early pointers are identified
that hold promise for their use in pharmacotherapy
of gastrointestinal sensory dysfunction.
DETECTION AND SIGNALLING OF GUT SYMPTOMS
Subtypes of sensory fibres
Peripheral endings of sensory afferent fibres can be
classified into five subtypes in the mouse gastro-
intestinal tract according to the location of their
mechanoreceptive fields.1 2 These are: mucosal,
muscular (or tension receptor), muscular–mucosal
(or tension–mucosal), serosal and mesenteric affer-
ents (fig 1).1–4 Mucosal afferents respond exclu-
sively to fine tactile stimulation of the luminal
surface. Anatomically, they appear as bare endings
in the lamina propria of villi.5 Muscular afferents
(or tension receptors) respond to distension at
physiological levels (,20 mm Hg), and have spe-
cialised terminals that surround myenteric gang-
lia.6–8 Serosal and mesenteric afferents respond at
noxious levels of distension (.40 mm Hg),1 4 9 10
and correspond to varicose branching axons close
to blood vessels.11 Muscular–mucosal afferents
respond to both tactile and distension stimuli,
but their anatomy has not been confirmed. These
five classifications were made based primarily on
functional observations, and we are still in the
process of matching structure with function. This
has probably led to the overlap in terminology
between tension-sensitive afferents in the upper
gastrointestinal tract (whose adequate stimulus
defines their nomenclature), and afferents sensitive
to distortion of muscle layers (defined according to
location of receptive field). Other classifications
have arisen in this and other species, but the
consensus appears to be that there are fibres with
low and high thresholds to distension, fibres that
are distension insensitive (probably mucosal affer-
ents) and a separate class of genuine mechanically
insensitive fibres that respond only to chemical
stimuli.12 13 To name fibres based on the layer of
the gut wall from which responses are most readily
evoked is probably misplaced until the structural
identity is confirmed anatomically. Thus, high
threshold afferents are not exclusively in the serosa
and mesentery, and may also be located in the
submucosa.11
Mucosal afferents are abundant throughout the
innervation of the gut, although scarce in the mid-
colon.1 The role of mucosal receptors is unlikely to
be in direct conscious perception of events in the
gut, except in the anal and pharyngeal regions,
where discrimination of solid, liquid and gas is
required. It is likely that elsewhere they are
important in refining the perception of other
events such as distension and contraction, and/or
in subliminal autonomic reflexes controlling gut
function and behaviour. Stimulation of mucosal
afferents in the stomach and small intestine is
commonly associated with reduced food intake
behaviour, nausea and vomiting, particularly after
activation by enteroendocrine mediators.14 Their
functions in the lower bowel remain to be
elucidated. Muscular–mucosal (or tension–mucosal)
receptors exist in the oesophagus and distal colon/
rectum which detect both tactile and distending
stimuli, combining the functions of muscular and
mucosal afferents in the same fibre. Their functional
role is undetermined, but it is possible they may play
a specialised role in detecting bolus or stool passage.
The roles of other populations of sensory fibres are
perhaps easier to envisage, with muscular (or
tension) receptors providing input into perception
of distension or contraction, and serosal mesenteric
afferents detecting overdistension, high amplitude
contraction, and distortion of blood vessels15 16
Although the structure and localisation of afferent
endings are very important in determining their
physiological and pathophysiological roles, the range
of ion channels, receptors and enzymes they express
may be equally important.
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Pathways to the central nervous system
Sensory nerves follow three main pathways from
the gastrointestinal tract to the central nervous
system—the vagal, splanchnic and pelvic nerves.
Vagal afferent fibres have neuronal cell bodies in
the nodose and jugular ganglia, whilst the splanch-
nic and pelvic innervations have cell bodies in
spinal thoracolumbar and lumbosacral dorsal root
ganglia (DRGs), respectively. Gastrointestinal
afferents in the vagal pathway (tension and
mucosal) are typically associated with sensations
such as satiety and nausea, although a subpopula-
tion of oesophageal vagal afferents responds at
high thresholds, implicating them in pain.17 Spinal
pathways innervate all viscera and are associated
with sensations of pain, discomfort, bloating and
urgency to void.15 Correspondingly, the majority of
vagal afferents innervating smooth muscle respond
over a restricted range of distension pressures,
whereas spinal afferents respond over a wide
dynamic range.4 18 19 There are differences within
the spinal innervation, such that the pelvic path-
way contains both non-nociceptive and nocicep-
tive afferents, whilst splanchnic afferents have
generally higher mechanical thresholds, with few
mucosal and muscular afferents, constituting
primarily a nociceptive pathway.1 Understanding
the specialised roles of TRP channels in visceral
pain will depend on determining which of the
afferent subtypes and pathways express particular
channels, and the consequence of blocking their
function in each subtype.
ROLES OF TRP CHANNELS IN SENSORY
SIGNALLING
The range available, and their localisation
The TRP family comprises five subfamilies (TRPA,
TRPC, TRPM, TRPP and TRPV) in mammals,
which share several key properties: they are non-
selective cation channels and most have six
transmembrane domains (fig 2). As their name
suggests, they were first identified as channels
mediating brief excitatory events in non-mamma-
lian sensory systems, although their roles have
outgrown this original label as evident from the
discussion below. They are grouped according to
their structural similarities, and are discussed
below in order of the interest that has been
expressed in them in visceral sensory pathways.
For a more complete review of their functions in
various physiological systems, see reviews by
Clapham,20 Dhaka et al21 and Christensen and
Corey.22 TRP channels have received fame and/or
notoriety in a number of fields, including pain,23
respiratory and cardiac function,24 25 ion metabo-
lism and absorption.26
TRPV
The TRPV, or vanilloid family, is probably the best
known subfamily of TRP channels, notably TRPV1
Figure 1 Schematic diagram showing the pathways and subtypes of gastrointestinal afferents, based mainly on our evidence from mouse
experiments for simplicity. The vagal and spinal pathways are shown on mirror images of the gut for clarity. The locations of endings are based on
functional localisation of mechanoreceptive fields, which in some cases is confirmed by anatomical studies. The splanchnic and pelvic innervations of
the colon overlap in the distal colon (not shown), otherwise they are distinct. Tension–mucosal and muscular–mucosal afferents are not shown, but
have properties consistent with a location of endings in both layers of the gut.
Recent advances in basic science
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which is activated by the vanilloid chilli extract
capsaicin. TRPV1 expression is greater in gut-
innervating neurons that in those innervating the
skin,27 with 50–60% of lumbosacral and 82% of
thoracolumbar colonic DRG neurons displaying
TRPV1 immunoreactivity,13 27 28 similar to the
proportion of thoracic gastric DRG neurons.29
TRPV1 is also found in peripheral terminals
throughout the gut,30 and in 40–80% of nodose
ganglion neurons innervating the stomach.29 31
TRPV4 is the mammalian homologue of the
Caenorhabditis elegans osmosensory gene Osm-932;
it responds to extracts of the herb Andrographis
paniculata.33 TRPV4 is located at sites of mechan-
ical stimulus detection including inner-ear hair
cells, sensory neurons and somatic mechanosen-
sory structures.32 TRPV4 appears to be enriched
within certain populations of sensory neurons in
the DRGs. There is greater TRPV4 mRNA expres-
sion in colonic sensory neurons than in whole
DRGs. Within the thoracolumbar (splanchnic)
DRGs, TRPV4 mRNA in identified colonic neurons
is 20 times that in whole DRGs. Differences
between pathways are also evident, with colonic
sensory neurons expressing 3–8 times the levels of
TRPV4 in identified gastric vagal sensory neurons.
TRPV4 is found in 38% of gastro-oesophageal vagal
neurons, 65–76% of splanchnic colonic DRG
neurons and 58% of pelvic colonic DRG neurons.3
In the periphery, TRPV4 protein co-localises with
calcitonin gene-related peptide (CGRP) in colonic
nerve fibres in the outermost (serosal and mesen-
teric) layers but is scarce in intramuscular or
mucosal endings. This pattern of localisation is
apparent in both mouse and human tissue,3 and
correlates well with the functional role of TRPV4
(see below). Other members of the vanilloid family
include TRPV2, 3, 5 and 6, whose function in the gut
has not yet been investigated. TRPV2 is expressed in
gastric vagal afferents, but not TRPV3.34
TRPA
The ankyrin, or TRPA family has only one
member—TRPA1—which is the mammalian
orthologue of the Drosophila gene painless, where
it is expressed in polymodal nociceptor endings and
contributes to the detection of intense mechanical
stimuli. It has a characteristic large number of
ankyrin protein repeats, thought to act as a spring
and intracellular anchor, which may contribute to
mechanosensory transduction35 (fig 2). It responds
to a range of environmental irritants36–38 and
extracts of mustard, cinnamon, garlic and ore-
gano39–42 (table 1). TRPA1 is localised in 55% of
gastro-oesophageal vagal afferents, 54% of splanch-
nic colonic afferents and 58% of pelvic colonic
afferents.43
TRPM
The melastatin, or TRPM family, was originally
named for the antimelanoma properties of
TRPM1. There are two members of interest:
TRPM8 is now widely researched because it
mediates the cooling and soothing sensation of
menthol, icilin and eucalyptol.21 44 Thus, TRPM8
may be critical in alleviating pain. TRPM8 is
localised in DRG neurons that do not co-localise
with the ‘‘algesic’’ TRP channels V1 and A1.45 It
would be most valuable to determine TRPM8
expression and function in specific subpopulations
of visceral afferents, which, by analogy with skin,
may have an antinociceptive function. TRPM5 is
localised in taste buds, where it is part of the
pathway leading to release of neurotransmitters
involved in various taste modalities.46 47 It is also
found in the gut epithelium, where it may serve a
similar function.48 49
TRPC
The canonical, or TRPC family has six members,
most of which operate as classical calcium channel
effectors, rather than sensors. Their sensory role in
the gut is currently being investigated. TRPC1 was
of interest, since it was shown to play a role in
mechanosensation in recombinant systems.50
However, this evidence has been refuted, and the
role of TRPC1 in mechanosensation has been cast
in doubt.51
TRPP
The polycystin, or TRPP family has four members,
TRPP1, 2, 3 and 5. Their name is derived from an
association between a TRPP mutation and poly-
cystic kidney disease. They play roles in develop-
mental guidance and ciliary function. TRPP1 (an




channels discussed in this
review. Extracellular is
shown uppermost. Note
the ankyrin repeats in
putative mechanosensitive
channels, and several of
them have interaction sites
where effector function can
be modulated. Modified
from Dhaka et al.21 PIP2,
phosphatidylinositol
bisphosphate.
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together as a heterodimer to act as a signalling
complex (also known as PKD1L3 and PKD2L1),
which is unlike other TRP channels where homo-
tetramers are the normal configuration. They
recently received interest in connection with a role
in acid sensing,52 53 although such a role in the gut
remains to be tested.
TRPML
The mucolipin, or TRPML family has three
members, one of which is associated with muco-
lipidosis. They have an intracellular function
putatively in vesicle formation20 and will not be
considered further here.
TRP channels as detectors
TRP channels are proposed to be primary transdu-
cers of thermal, mechanical and chemical stimuli.
Thermal transduction is unlikely to be important in
the gut and will not be discussed in detail. There are
several mechanosensory and chemosensory proper-
ties (table 1 and outlined below) that make
particular TRP channels important targets for
investigation in gastrointestinal sensory pathways.
In contrast to their established roles as chemosen-
sors, conclusive evidence that TRP channels function
as mechanosensors has been elusive as this requires
mechanosensory function studies from isolated
channels to intact sensory fibres to intact animals.
TRPV
TRPV1 is activated by capsaicin, noxious heat, low
pH and a range of herb and spice extracts (table 1).
We are all familiar with the burning sensation
evoked by capsaicin applied to the mouth or
mucous membranes, and when administered intra-
colonically it causes pronounced pain.54 However,
capsaicin also activates non-nociceptive upper
gastrointestinal vagal afferents,55 which may be
relevant to symptoms generated in humans,
discussed later. Genetic deletion of TRPV1 has no
significant effect on mechanosensory function of
somatic nociceptors,56 but there are deficits in
TRPV12/2 visceral mechanoreceptors (table 2). In
the gastro-oesophageal region TRPV1 knockouts
had reduced vagal afferent responses to disten-
sion.57 TRPV1 knockouts also have significantly
reduced responses of jejunal wide-dynamic range
afferents to distension, but had normal function of
low or high threshold afferents.58 In the distal
colon/rectum TRPV1 deletion significantly reduced
the distension responses of pelvic muscular and
muscular–mucosal afferents,59 but not responses to
mucosal stroking. Effects on serosal afferents were
not reported. Therefore, TRPV1 deletion consis-
tently reduces the mechanosensitivity of disten-
sion-sensitive gastro-oesophageal, jejunal and
pelvic colonic afferents. Similar deficits were found
in bladder afferents.60 Capsaicin potently activates
splanchnic and pelvic colonic serosal afferents,
which is followed by pronounced mechanical
desensitisation in splanchnic but not pelvic affer-
ents.13 This suggests that the coupling of TRPV1
differs between pathways. Whereas TRPV12/2
mice had normal somatic mechanical pain sensi-
tivity,56 their behavioural responses to colorectal
distension were reduced.59 Therefore, TRPV1 is
important in the signalling of physiological
mechanical stimuli from throughout the viscera.
Since TRPV1 normally responds to low pH,61
this makes it a prime candidate for the sensing of
refluxed acid in the oesophagus, and giving rise to
the sensation of heartburn. Indeed it has been
detected in fibres innervating the human oesopha-
geal mucosa.62 63 Mice lacking TRPV1 channels
develop significantly less oesophagitis after acid
exposure compared with wild-type mice,64 suggest-
ing a role beyond sensory function. In the guinea-
pig, oesophageal tension-sensitive vagal afferents
termed ‘‘nociceptive-like’’ are distinguishable from
‘‘non-nociceptive-like’’ afferents by their respon-
siveness to capsaicin.17 These ‘‘nociceptive-like’’
tension receptors in the oesophagus are stimulated
by acid.65 In contrast, the responses of ‘‘non-
nociceptive’’ tension receptors to acid are less well
defined. Rong et al58 showed that responses of
jejunal afferents to acid were reduced up to 50% in
TRPV1 knockouts, indicating a major, but not
exclusive role for TRPV1 in detecting low pH.
TRPV4 is involved in the transduction of
osmotic stimuli and is also implicated in mechan-
osensory function, since TRPV42/2 mice show
reduced behavioural sensitivity to noxious somatic
mechanical stimuli.32 66 The role of TRPV4 in the
viscera is more discrete (table 2): deletion of TRPV4
had no effect on vagal afferent function,3 consis-
tent with low TRPV4 expression in gastro-oeso-
phageal vagal afferents. However, in colonic
afferents, where TRPV4 is enriched, mechanosen-
sory responses were dramatically reduced in
TRPV4 knockouts, and mechanosensory thresh-
olds were increased. This was the case for both
Table 1 A select list of transient receptor potential (TRP) channels, their natural ligands,
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splanchnic and pelvic high threshold (serosal and
mesenteric) afferents, which was consistent with
TRPV4 expression in the periphery. These deficits
were restricted to mechanosensory function, since
afferent excitability, electrical thresholds and con-
duction velocities were identical in TRPV42/2 and
TRPV4+/+ mice. However, as was the case in the
vagal pathway, pelvic mucosal and muscular
afferents were normal. Thus, TRPV4 makes a
specific and major contribution to colonic high
threshold mechanosensory afferent function, and
as such is the only nociceptor-specific TRP channel
as yet identified.
Opening the TRPV4 channel pharmacologically
increases the afferent response to mechanical
stimuli. The endogenous arachidonic acid metabo-
lite 5,6-EET is an agonist of TRPV4, which causes
significant potentiation of mechanosensory
responses in wild-type mice, but not in TRPV4
knockouts. Pharmacological blockade with the
non-selective TRP channel blocker ruthenium red
correspondingly reduces mechanosensitivity only
in wild-type mice.3 67 Consistent with effects of
TRPV4 activation in colonic afferent endings, 4a-
PDD, a synthetic TRPV4 agonist, caused signifi-
cant TRPV4-mediated calcium influx in isolated
colonic DRG neurons.68 From these data it is clear
that alterations in the pharmacology of splanchnic
and pelvic colonic afferents parallel the changes in
mechanosensitivity in TRPV4 knockouts, indicat-
ing that there may be potential for development of
a nociceptor-specific analgesic.
The selective role of TRPV4 in high threshold
afferents would be expected to translate into a role
in pain perception in vivo, which was indeed the
case. There were decreased abdominal electromyo-
graphic (EMG) responses to noxious colorectal
distension in TRPV4 knockouts or in mice with
downregulated TRPV4 expression (via interverteb-
ral small interfering RNA (siRNA) delivery).3 68
This was apparent particularly at higher distension
pressures. Intracolonic administration of 4a-PDD in
wild-type mice caused neuronal activation in the
lumbosacral spinal cord and caused dose-dependent
visceral hypersensitivity to colorectal distension.68
TRPA
TRPA1 was originally thought to play a role in hair
cells of the inner ear, but TRPA12/2 mice have
normal hearing.36 69 One line of TRPA1-deficient
mice has increased pain thresholds to somatic
mechanical stimuli,69 but another line had normal
responses to noxious stimuli,36 so the contribution
of TRPA1 to somatosensory function is unresolved.
Its role in the gut is becoming clearer, although
results are still preliminary. TRPA12/2 mice have
reduced mechanosensitivity of mucosal afferents in
vagal and pelvic pathways. TRPA1 deletion also
reduced the stimulus–response functions of high
threshold colonic splanchnic and pelvic serosal and
mesenteric afferents. However, the distension
responses of vagal tension receptors and pelvic
muscular and muscular–mucosal afferents were
unaltered.43 Taken together these data suggest
paradoxically that TRPA1 contributes to mechan-
osensation in both tactile and nociceptive affer-
ents, but not in others.
A nociceptive role for TRPA1 was also apparent
in vivo; intrathecal administration of TRPA1
antisense oligodeoxynucleotide in rats (to reduce
TRPA1 expression in DRGs) reduced the colitis-
induced hyperalgesia to nociceptive colonic disten-
sion and intracolonic mustard oil.70 Although
TRPA1 may not be as specific in its role as
TRPV4, it is clearly evident as a target for reducing
signalling of pain from the colon. When its role in
mucosal afferents emerges, this may provide
important insight into not only the functional role
of the channel, but also the role of this subtype of
afferents in sensation from the lower gut.
TRPM
Evidence for or against TRPM8 as a mechanosensor
is lacking. Activation of a subpopulation of
cutaneous sensory neurons by TRPM8 agonists
elicits analgesia in chronic pain models in rats,
which is blocked by siRNA knockdown of
TRPM8.71 This analgesic effect of TRPM8-sensitive
afferents is probably centrally mediated through
activation of inhibitory interneurons in the spinal
dorsal horn. This is similar to a somatosensory
Table 2 A summary of the effects of selected transient receptor potential (TRP) channel deletion, utilising knockout mice, on intestinal afferent
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Arrows indicate the degree of change in mechanosensory function. Empty cells indicate not tested.
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process known as ‘‘gate control’’,72 which underlies
the analgesic effects of massage and transcuta-
neous electrical nerve stimulation. Although the
exact mechanisms involved are unknown, the role
of TRPM8 in gate control is potentially important.
TRPM8 agonists are already known to activate
non-nociceptive vagal afferent neurons innervating
the gut.34
TRPP
TRPP1 and 2 are recent mechanosensory candi-
dates in the primary cilium of kidney cells73 and are
suggested to be important in ciliated mechanosen-
sory structures that detect very small forces.
Therefore, this may be important in colonic
mucosal afferents which are highly tactile. It was
recently shown that PKD1L3 and PKD2L1 are
activated by various acids at pH ,3 when co-
expressed in heterologous cells but not by other
classes of tastants.52 53 These results suggest that
TRPPs may function as sour taste receptors, which
begs the question as to whether they may be
involved in the detection of refluxed acid in the
oesophagus. Since knockouts of these channels are
lethal, advances in the field may well depend on
novel pharmacology in recombinant systems.
TRP channels as effectors
TRP channels can also function as effectors,
mediating excitation of cells in response to activa-
tion of G-protein-coupled receptors and other
channels (table 1). This is an important aspect of
the biology of most TRP subfamilies, and in some
cases it is their only identified role, for example in
some members of the TRPC family.74 The effector
function of TRP channels is, however, important in
sensory nerve function, such as inflammatory pain
evoked by the mediators bradykinin36 and mast cell
proteases.75 TRPV1 is not considered to be directly
mechanically gated; therefore, the effects on
mechanosensation may be mainly due to indirect
effects on neuron excitability or via interactions
with other receptors or TRP channels. For example,
5-hydroxytryptamine (5-HT) enhances sensitivity
to heat in colonic DRG neurons via TRPV176, which
leads to excitation at normal body temperature.
Protease-activated receptor 2 (PAR2) sensitises
TRPV1 through defined intracellular pathways.77
Cannabinoids modulate TRPV1 either by a direct
interaction of the eicosanoid mediator anandamide
with the channel itself, or by coupling through
intracellular pathways after acting on G-protein-
coupled cannabinoid receptors.78 79
In addition to its coupling with TRPV1, there is
also evidence for a strong interaction of PAR2 with
TRPV4, which may contribute to visceral hyper-
sensitivity.67 68 TRPV4 and PAR2 are co-expressed
in a large proportion of colonic sensory neurons.67 68
In isolated colonic DRG neurons, PAR2-activating
peptide (AP) sensitises TRPV4-mediated currents,
whilst PAR2 AP also activates splanchnic serosal
colonic afferent endings, but not in TRPV4 knock-
outs.67 Intracolonic administration of PAR2 AP
increases the behavioural response to noxious
colorectal distension, an effect also lost in
TRPV42/2 mice.67 68
PAR2 interacts with TRPA1 via similar intracel-
lular mechanisms to those involved with TRPV1.80
TRPA1 can also be indirectly activated by bradyki-
nin,36 81 and mediates bradykinin-induced mechan-
ical hypersensitivity in the guinea-pig oesophagus.82
In the colon bradykinin induces mechanical hyper-
sensitivity in splanchnic serosal afferents,12 which is
lost in fibres from TRPA12/2 mice.43
Other TRP channels are also associated with
bradykinin activation, including TRPC1, whereby
specific signalling from the BK2 receptor opens
TRPC1.83 Thus TRPC1, like TRPV4 and TRPA1,
interacts with inflammatory G-protein-coupled
receptors. However, in contrast to TRPV1,
TRPA1 and TRPC1, which are all sensitised by
BK2 receptor activation, TRPM8 function is
inhibited by bradykinin via a reduction in intra-
cellular phosphoinositide (PIP2) levels.
21 84
In addition to its role in neurons, there is
emerging evidence for involvement of TRPA1 in
mediator release from enteroendocrine cells.
Enterochromaffin cells express TRPA1 and release
serotonin cholecystikinin (CCK) in response to
mustard oil,85 which also releases CCK from the
enteroendocrine cell line STC-1,86 suggesting that
dietary spices may augment release of mucosal
mediators in response to nutrients.
Although the role of TRPM5 is best established in
the tongue, as a channel that couples taste receptor
activation with cation influx, via the G-protein–
phospholipase C pathway,46 47 it is also known to be
expressed in the gut epithelium, where it may serve a
similar ‘‘tasting’’ function. In keeping with this, its
expression is regulated by changes in luminal or
systemic glucose concentration.49
Although TRP channels function as effectors for
many pathways, single TRP knockouts normally
retain some response to the initial stimulus, for
example in bradykinin-evoked excitation of airway
afferents,87 suggesting that there are parallel
mechanisms—either other TRP channels or com-
pletely distinct pathways.
TRP channels may interact with one another, for
example TRPA1 and TRPV1 are often co-localised
in nociceptive DRG neurons, where a TRPA1
agonist causes cross-desensitisation of responses
to capsaicin, and vice versa.87 Whether or not TRP
channels may couple together positively, and
therefore act as effectors for one another, is not
yet evident.
CHANGES IN SENSORY SIGNALLING IN DISEASE
The effects of inflammation on visceral afferent
endings have been studied by several groups, with
a view to finding a model for postinfectious
irritable bowel syndrome (eg, Mayer and
Gebhart89). The majority of electrophysiological
studies in the literature have focused on the
responses of afferents to colorectal distension and
how this is altered by inflammation. A recent
study by DeSchepper et al90 showed that acute
Recent advances in basic science
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trinitrobenzene sulfonic acid (TNBS) colitis in rats
increased the response to colorectal distension of
pelvic afferent C-fibres in vivo; the increased
sensitivity to distension was reduced by a TRPV1
antagonist. An earlier study by Sengupta et al91
using an identical in vivo rat TNBS protocol
recording from the same population of afferents
did not reveal any changes in mechanosensitivity,
so there is clearly controversy in this area. In
agreement with Sengupta’s91 findings in rat, Jones
et al92 saw no change in mechanosensitivity of
pelvic muscular or muscular–mucosal afferents in a
mouse zymosan colonic inflammation model. The
behavioural response to colorectal distension was,
however, increased after zymosan, and this
remained to an extent in TRPV1 knockouts, so
the mechanism underlying pain hypersensitivity
was not revealed. In a model of colonic hypersen-
sitivity induced by colonic irritation in neonatal
rats,93 TRPV1 inhibitors were effective in reducing
pain responses to colorectal distension. Increased
expression of TRPV1 in DRGs is evident in this
model, as well as in a TNBS colitis model,94
suggesting that TRPV1 upregulation may be a
mechanism by which the effect of a TRPV1
antagonist becomes manifest. In a model of pan-
creatic inflammation this mechanism was con-
firmed.95 The upregulation of function via TRPV1
can be long lasting, and may initiate other events
leading to hypersensitivity.93 94 Alternatively, the
translocation of TRPV1 to the cell membrane may
have an important influence on its function
independent of changes in expression.96 Studies of
biopsies from patients with visceral hypersensitivity,
either in irritable bowel syndrome (IBS)97 (fig 3) or in
non-erosive reflux disease,63 show that mucosal
fibres containing TRPV1 may be increased in
number up to 3.5-fold, and that this increase may
correlate with symptoms. Chan et al98 showed that
increased rectal sensitivity was associated with
increased TRPV1 fibres in all layers of the gut wall.
Mustard oil, which we now know to be a
selective TRPA1 agonist, has long been used as a
visceral inflammatory model to sensitise nocicep-
tors and provoke tissue damage.54 This suggests
that TRPA1 has a role not only in activation of
sensory pathways, but also in local neurogenic
inflammation, presumably after evoking release of
peptides such as substance P from peripheral
endings. Studies are ongoing to determine if
TRPA1 function or expression is increased in
inflammatory models or patients with IBS.
From the perspective of active inhibition of
visceral pain the observation is worth noting that a
combination of peppermint oil (a TRPM8 agonist)
and caraway oil attenuates postinflammatory visc-
eral hyperalgesia in rats,99 which may correlate with
its therapeutic effects in patients described below.
THERAPEUTIC OPPORTUNITIES
A hallmark of functional gastrointestinal disorders is
allodynia and hyperalgesia to mechanical events,100–102
and low-grade inflammatory status.103–105 Therefore,
treatments are needed that reduce signalling of
nociceptive mechanosensory and inflammatory
events. TRP channels are clearly involved in both of
these processes. Normally, there is a constant stream
of subliminal information from the gut, which is
involved in autonomic reflexes controlling motor and
secretory function. It is therefore important to
distinguish this information from nociceptive signals
in targeting visceral pain to avoid altering normal gut
function. So far, TRPV4 is the only TRP channel that
appears to be nociceptor specific, but ironically is the
least well served pharmacologically. As with many
other TRP channels, its localisation is not, however,
confined to sensory neurons,105 so the potential exists
for off-target adverse effects. Such effects have
applied powerful brakes to the progress of other
types of treatments for visceral pain, but it could be
argued that in the case of TRP channels, there are
fewer other target tissues to be concerned about. We
hope this article may provide a stimulus for further
development of selective drugs, either as pharmaco-
logical treatments or as tools to investigate the roles
of TRP channels more effectively. Another interest-
ing application of TRP channel pharmacology is in
diagnostic testing for functional gastrointestinal
disorders. Administration of a capsaicin capsule
produces more symptoms including pain, warmth
and pressure in patients with functional dyspepsia
compared with controls.107 Although the predictive
value is far from ideal—only half the patient cohort
were responsive—there is promise for development
of better provocative tests for functional disorders,
considering we have very few options currently.
Herbal preparations containing peppermint have
been successful in the treatment of functional
dyspepsia,108 although whether this is a sensory or
motor effect and whether it is mediated via
TRPM8 remain to be seen. Several clinical trials
have been conducted with selective TRP channel
antagonists for pain,109 such as the TRPV1 antago-
nist, AMG-517, which was discontinued due to
causing hyperthermia after systemic administra-
tion. Pharmaceutical companies are currently
Figure 3 Number of transient receptor potential V1
(TRPV1)-immunoreactive fibres/mm2 in rectosigmoid
biopsies from patients with irritable bowel syndrome (IBS)
and control groups; p = 0.001. From Akbar et al97, with
permission.
Recent advances in basic science
132 Gut 2010;59:126–135. doi:10.1136/gut.2009.179523
 group.bmj.com on January 9, 2013 - Published by gut.bmj.comDownloaded from 
determining whether this liability for TRPV1
antagonists can be managed. Site-specific adminis-
tration of TRPV1 desensitisation gets around this
issue, and has shown promise in other visceral
neurological disease, reviewed elsewhere,110 111 but
whether the gut is an appropriate place for site-
specific interventions remains a difficult question.
By far the greatest attention has been given to
TRPV1 as a therapeutic target, and there is still
potential for its successful exploitation despite the
current problems, not only in visceral pain, but also
in neurogenic inflammation.112 Hopefully it is clear
from this review that there are many other
emerging candidates within the TRP family. We
discussed earlier evidence that the role of TRP
channels may be increased in pathological condi-
tions such as IBS; this suggests that normalising
their function may be sufficient for therapeutic
benefit without blocking their function totally,
and may provide more scope for entry of com-
pounds into the market. It is also possible that the
role of TRP channels as effectors for other
receptors associated with pain may provide a
bonus in the antinociceptive actions of anti-TRP
treatment.
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